CYP27A1
炎症
低密度脂蛋白受体
内科学
医学
化学
胆固醇
造血
癌症研究
细胞生物学
生物
干细胞
脂蛋白
作者
Tim Hendrikx,Mike L. J. Jeurissen,Veerle Bieghs,Sofie M. A. Walenbergh,Patrick J. van Gorp,Fons Verheyen,Tom Houben,Yasmin Dias Guichot,Marion J. Gijbels,Eran Leitersdorf,Marten H. Hofker,Dieter Lütjohann,Ronit Shiri‐Sverdlov
标识
DOI:10.1016/j.jhep.2014.09.027
摘要
Background & Aims Non-alcoholic steatohepatitis (NASH) is characterized by hepatic lipid accumulation and inflammation. Currently, the underlying mechanisms, leading to hepatic inflammation, are still unknown. The breakdown of free cholesterol inside Kupffer cells (KCs) by the mitochondrial enzyme CYP27A1 produces 27-hydroxycholesterol (27HC). We recently demonstrated that administration of 27HC to hyperlipidemic mice reduced hepatic inflammation. In line, hematopoietic deletion of Cyp27a1 resulted in increased hepatic inflammation. In the current manuscript, the effect of hematopoietic overexpression of Cyp27a1 on the development of NASH and cholesterol trafficking was investigated. We hypothesized that Cyp27a1 overexpression in KCs will lead to reduced hepatic inflammation. Methods Irradiated Ldlr −/− mice were transplanted (tp) with bone marrow from mice overexpressing Cyp27a1 ( Cyp27a1 over ) and wild type (Wt) mice and fed either chow or a high-fat, high-cholesterol (HFC) diet for 3months. Additionally, gene expression was assessed in bone marrow-derived macrophages (BMDM) from Cyp27a1 over and Wt mice. Results In line with our hypothesis, hepatic inflammation in HFC-fed Cyp27a1 over -tp mice was reduced and KCs were less foamy compared to Wt-tp mice. Remarkably, these changes occurred even though plasma and liver levels of 27HC did not differ between both groups. BMDM from Cyp27a1 over mice revealed reduced inflammatory gene expression and increased expression of cholesterol transporters compared to Wt BMDM after lipopolysaccharide (LPS) stimulation. Conclusions Our data suggest that overexpression of Cyp27a1 in KCs reduces hepatic inflammation independently of 27HC levels in plasma and liver, further pointing towards KCs as specific target for improving the therapy of NASH.
科研通智能强力驱动
Strongly Powered by AbleSci AI